Xylazine: The zombie drug? (notice n° 1745354)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01288cam a2200193 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260322005047.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Frances, Pierre |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Xylazine: The zombie drug? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 64 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "Tranq," or "the zombie drug," is a drug that commonly combines xylazine and fentanyl. Addiction to this drug has become a scourge in the United States, where the number of overdoses related to the drug's consumption has increased exponentially since 2018. These two substances are the cause of mainly neurological effects, including motor inertia, dysarthria, and temporal and spatial disorientation; cutaneous effects with ulcers due to tissue hypoperfusion; and cardiovascular effects, including bradycardia and hypotension, and respiratory depression. Health care professionals treating these patients must focus on withdrawal management, but also be aware of the ineffectiveness of naloxone in counteracting side effects. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bernal, Carla |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gaubert, Robert |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Manjaoui, Sami |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Médecine | 21 | 1 | 2025-03-03 | p. 18-21 | 1777-2044 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-medecine-2025-1-page-18?lang=en&redirect-ssocas=7080">https://stm.cairn.info/revue-medecine-2025-1-page-18?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux